Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Georges El Fakhri, Ph.D.

Co-Author

This page shows the publications co-authored by Georges El Fakhri and Daniel Yokell.
Connection Strength

1.265
  1. Development, validation and regulatory acceptance of improved purification and simplified quality control of [13N] Ammonia. EJNMMI Radiopharm Chem. 2020 May 13; 5(1):11.
    View in: PubMed
    Score: 0.897
  2. A report of the automated radiosynthesis of the tau positron emission tomography radiopharmaceutical, [18 F]-THK-5351. J Labelled Comp Radiopharm. 2017 02; 60(2):140-146.
    View in: PubMed
    Score: 0.178
  3. In vivo quantitative mapping of human mitochondrial cardiac membrane potential: a feasibility study. Eur J Nucl Med Mol Imaging. 2021 02; 48(2):414-420.
    View in: PubMed
    Score: 0.057
  4. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects. Eur J Nucl Med Mol Imaging. 2019 Sep; 46(10):2099-2111.
    View in: PubMed
    Score: 0.053
  5. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects. J Nucl Med. 2017 Mar; 58(3):484-491.
    View in: PubMed
    Score: 0.044
  6. First human use of a radiopharmaceutical prepared by continuous-flow microfluidic radiofluorination: proof of concept with the tau imaging agent [18F]T807. Mol Imaging. 2014; 13.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.